The north american respiratory inhaler market is evolving rapidly. Due to an increase in respiratory diseases like asthma, COPD, and allergies, inhalers have become a lifeline for millions. The North American market for respiratory inhalers is forecasted to grow at a CAGR of 5.9% from 2024 to 2032. This expansion is not just about meeting medical n